文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

基于 2013 年至 2018 年文献的无定形二氧化硅危害评估的系统评价。

A Systematic Review on the Hazard Assessment of Amorphous Silica Based on the Literature From 2013 to 2018.

机构信息

NanoCASE GmbH, Engelburg, Switzerland.

Empa-Swiss Federal Laboratories for Science and Materials Technology, St. Gallen, Switzerland.

出版信息

Front Public Health. 2022 Jun 15;10:902893. doi: 10.3389/fpubh.2022.902893. eCollection 2022.


DOI:10.3389/fpubh.2022.902893
PMID:35784253
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9240267/
Abstract

BACKGROUND: Nanomaterials are suspected of causing health problems, as published studies on nanotoxicology indicate. On the other hand, some of these materials, such as nanostructured pyrogenic and precipitated synthetic amorphous silica (SAS) and silica gel, have been used for decades without safety concerns in industrial, commercial, and consumer applications. However, in addition to many and studies that have failed to demonstrate the intrinsic toxicity of SAS, articles periodically emerge, in which biological effects of concern have been described. Even though most of these studies do not meet high-quality standards and do not always use equivalent test materials or standardized test systems, the results often trigger substance re-evaluation. To put the results into perspective, an extensive literature study was carried out and an example of amorphous silica will be used to try to unravel the reliability from the unreliable results. METHODS: A systematic search of studies on nanotoxicological effects has been performed covering the years 2013 to 2018. The identified studies have been evaluated for their quality regarding material and method details, and the data have been curated and put into a data collection. This review deals only with investigations on amorphous silica. RESULTS: Of 18,162 publications 1,217 have been selected with direct reference to experiments with synthetically produced amorphous silica materials. The assessment of these studies based on defined criteria leads to a further reduction to 316 studies, which have been included in this systematic review. Screening for quality with well-defined quantitative criteria following the GUIDE nano concept reveals only 27.3% has acceptable quality. Overall, the and data showed low or no toxicity of amorphous silica. The data shown do not support the hypothesis of dependency of biological effects on the primary particle size of the tested materials. CONCLUSION: This review demonstrates the relatively low quality of most studies published on nanotoxicological issues in the case of amorphous silica. Moreover, mechanistic studies are often passed off or considered toxicological studies. In general, standardized methods or the Organization for Economic Cooperation and Development (OECD) guidelines are rarely used for toxicological experiments. As a result, the significance of the published data is usually weak and must be reevaluated carefully before using them for regulatory purposes.

摘要

背景:纳米材料被怀疑会导致健康问题,这一点在已发表的纳米毒理学研究中有所体现。另一方面,这些材料中的一些,如纳米结构的热解和沉淀合成无定形二氧化硅(SAS)和硅胶,已经在工业、商业和消费应用中使用了几十年,而没有安全问题。然而,除了许多未能证明 SAS 固有毒性的研究之外,定期会出现一些文章,其中描述了令人关注的生物效应。尽管这些研究中的大多数不符合高质量标准,并不总是使用等效的测试材料或标准化的测试系统,但结果往往会引发物质重新评估。为了正确看待这些结果,我们进行了广泛的文献研究,并以无定形二氧化硅为例,试图从不可靠的结果中梳理出可靠性。

方法:对 2013 年至 2018 年期间纳米毒理学效应的研究进行了系统搜索。对确定的研究进行了质量评估,包括对材料和方法细节的评估,并对数据进行了整理和收集。本综述仅涉及对无定形二氧化硅的研究。

结果:在 18162 篇出版物中,有 1217 篇直接提到了用合成法生产的无定形二氧化硅材料进行的实验。根据既定标准对这些研究进行评估,导致进一步减少到 316 项研究,这些研究被纳入本系统综述。采用经过明确定义的定量标准进行筛选,根据 GUIDE nano 概念评估质量,结果仅显示 27.3%的研究具有可接受的质量。总的来说,和数据表明无定形二氧化硅的毒性较低或没有毒性。所显示的数据不支持生物效应依赖于所测试材料的初级颗粒大小的假设。

结论:本综述表明,在无定形二氧化硅的纳米毒理学问题方面,大多数已发表的研究的质量相对较低。此外,机制研究通常被忽略或被认为是毒理学研究。一般来说,很少使用标准化方法或经济合作与发展组织(OECD)指南进行毒理学实验。因此,所发表数据的意义通常较弱,在将其用于监管目的之前,必须仔细重新评估。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1e6/9240267/a404a56614a4/fpubh-10-902893-g0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1e6/9240267/e42c1d7c0746/fpubh-10-902893-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1e6/9240267/463b441fc3f1/fpubh-10-902893-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1e6/9240267/fac870ec363b/fpubh-10-902893-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1e6/9240267/90d6c0475a02/fpubh-10-902893-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1e6/9240267/1657779ecfd6/fpubh-10-902893-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1e6/9240267/60d8e07cc698/fpubh-10-902893-g0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1e6/9240267/a404a56614a4/fpubh-10-902893-g0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1e6/9240267/e42c1d7c0746/fpubh-10-902893-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1e6/9240267/463b441fc3f1/fpubh-10-902893-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1e6/9240267/fac870ec363b/fpubh-10-902893-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1e6/9240267/90d6c0475a02/fpubh-10-902893-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1e6/9240267/1657779ecfd6/fpubh-10-902893-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1e6/9240267/60d8e07cc698/fpubh-10-902893-g0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1e6/9240267/a404a56614a4/fpubh-10-902893-g0007.jpg

相似文献

[1]
A Systematic Review on the Hazard Assessment of Amorphous Silica Based on the Literature From 2013 to 2018.

Front Public Health. 2022

[2]
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.

Health Technol Assess. 2006-9

[3]
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.

Health Technol Assess. 2001

[4]
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.

Health Technol Assess. 2001

[5]
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.

Cochrane Database Syst Rev. 2022-5-20

[6]
Systemic treatments for metastatic cutaneous melanoma.

Cochrane Database Syst Rev. 2018-2-6

[7]
Comparison of cellulose, modified cellulose and synthetic membranes in the haemodialysis of patients with end-stage renal disease.

Cochrane Database Syst Rev. 2001

[8]
Home treatment for mental health problems: a systematic review.

Health Technol Assess. 2001

[9]
The clinical effectiveness and cost-effectiveness of enzyme replacement therapy for Gaucher's disease: a systematic review.

Health Technol Assess. 2006-7

[10]
Comparison of the effectiveness of inhaler devices in asthma and chronic obstructive airways disease: a systematic review of the literature.

Health Technol Assess. 2001

本文引用的文献

[1]
Collection of Controlled Nanosafety Data-The CoCoN-Database, a Tool to Assess Nanomaterial Hazard.

Nanomaterials (Basel). 2022-1-28

[2]
Emerging Technologies for In Vitro Inhalation Toxicology.

Adv Healthc Mater. 2021-9

[3]
A strategy towards the generation of testable adverse outcome pathways for nanomaterials.

ALTEX. 2021

[4]
Interaction of nanoparticles with endotoxin .

Nanotoxicology. 2021-5

[5]
Non-Animal Strategies for Toxicity Assessment of Nanoscale Materials: Role of Adverse Outcome Pathways in the Selection of Endpoints.

Small. 2021-4

[6]
Cause-and-Effect Analysis as a Tool To Improve the Reproducibility of Nanobioassays: Four Case Studies.

Chem Res Toxicol. 2020-5-18

[7]
Toxicological evaluation of airborne particulate matter. Are cell culture technologies ready to replace animal testing?

J Appl Toxicol. 2019-4-25

[8]
Particle toxicology and health - where are we?

Part Fibre Toxicol. 2019-4-23

[9]
Review of emerging concepts in nanotoxicology: opportunities and challenges for safer nanomaterial design.

Toxicol Mech Methods. 2019-2-12

[10]
What is the impact of surface modifications and particle size on commercial titanium dioxide particle samples? - A review of in vivo pulmonary and oral toxicity studies - Revised 11-6-2018.

Toxicol Lett. 2018-11-20

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索